vs
Royalty Pharma plc（RPRX）与Ubiquiti Inc.（UI）财务数据对比。点击上方公司名可切换其他公司
Ubiquiti Inc.的季度营收约是Royalty Pharma plc的1.3倍（$814.9M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 28.7%，领先5.8%），Ubiquiti Inc.同比增速更快（35.8% vs 4.8%），过去两年Ubiquiti Inc.的营收复合增速更高（28.6% vs 4.6%）
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
Ubiquiti Inc.是一家美国科技企业，2003年于加利福尼亚州圣何塞成立，目前总部位于纽约。公司旗下拥有多个品牌，主营面向企业及家庭用户的有线、无线数据通信产品的研发、生产与销售。
RPRX vs UI — 直观对比
营收规模更大
UI
是对方的1.3倍
$622.0M
营收增速更快
UI
高出31.1%
4.8%
净利率更高
RPRX
高出5.8%
28.7%
两年增速更快
UI
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $622.0M | $814.9M |
| 净利润 | $214.2M | $233.6M |
| 毛利率 | — | 45.9% |
| 营业利润率 | 62.4% | 35.9% |
| 净利率 | 34.4% | 28.7% |
| 营收同比 | 4.8% | 35.8% |
| 净利润同比 | 2.9% | 70.8% |
| 每股收益（稀释后） | $0.49 | $3.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RPRXUI
| Q4 25 | $622.0M | $814.9M | ||
| Q3 25 | $609.3M | $733.8M | ||
| Q2 25 | $578.7M | $759.2M | ||
| Q1 25 | $568.2M | $664.2M | ||
| Q4 24 | $593.6M | $599.9M | ||
| Q3 24 | $564.7M | $550.3M | ||
| Q2 24 | $537.3M | $507.5M | ||
| Q1 24 | $568.0M | $493.0M |
净利润RPRXUI
| Q4 25 | $214.2M | $233.6M | ||
| Q3 25 | $288.2M | $207.9M | ||
| Q2 25 | $30.2M | $266.7M | ||
| Q1 25 | $238.3M | $180.4M | ||
| Q4 24 | $208.2M | $136.8M | ||
| Q3 24 | $544.0M | $128.0M | ||
| Q2 24 | $102.0M | $103.8M | ||
| Q1 24 | $4.8M | $76.3M |
毛利率RPRXUI
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 46.0% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 44.5% | ||
| Q4 24 | — | 41.2% | ||
| Q3 24 | — | 42.1% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 35.3% |
营业利润率RPRXUI
| Q4 25 | 62.4% | 35.9% | ||
| Q3 25 | 70.1% | 35.7% | ||
| Q2 25 | 36.3% | 34.4% | ||
| Q1 25 | 94.0% | 34.2% | ||
| Q4 24 | 60.9% | 29.8% | ||
| Q3 24 | — | 30.7% | ||
| Q2 24 | 50.2% | 27.3% | ||
| Q1 24 | -13.0% | 22.6% |
净利率RPRXUI
| Q4 25 | 34.4% | 28.7% | ||
| Q3 25 | 47.3% | 28.3% | ||
| Q2 25 | 5.2% | 35.1% | ||
| Q1 25 | 41.9% | 27.2% | ||
| Q4 24 | 35.1% | 22.8% | ||
| Q3 24 | 96.3% | 23.3% | ||
| Q2 24 | 19.0% | 20.5% | ||
| Q1 24 | 0.8% | 15.5% |
每股收益（稀释后）RPRXUI
| Q4 25 | $0.49 | $3.86 | ||
| Q3 25 | $0.67 | $3.43 | ||
| Q2 25 | $0.07 | $4.40 | ||
| Q1 25 | $0.55 | $2.98 | ||
| Q4 24 | $0.46 | $2.26 | ||
| Q3 24 | $1.21 | $2.12 | ||
| Q2 24 | $0.23 | $1.72 | ||
| Q1 24 | $0.01 | $1.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $618.7M | $302.8M |
| 总债务越低越好 | $9.0B | $47.5M |
| 股东权益账面价值 | $9.7B | $1.0B |
| 总资产 | $19.6B | $1.6B |
| 负债/权益比越低杠杆越低 | 0.92× | 0.05× |
8季度趋势，按日历期对齐
现金及短期投资RPRXUI
| Q4 25 | $618.7M | $302.8M | ||
| Q3 25 | $938.9M | $177.2M | ||
| Q2 25 | $631.9M | $149.7M | ||
| Q1 25 | $1.1B | $151.0M | ||
| Q4 24 | $929.0M | $133.1M | ||
| Q3 24 | $950.1M | $165.2M | ||
| Q2 24 | $1.8B | $126.3M | ||
| Q1 24 | $843.0M | $102.5M |
总债务RPRXUI
| Q4 25 | $9.0B | $47.5M | ||
| Q3 25 | $8.9B | $133.8M | ||
| Q2 25 | $8.0B | $250.0M | ||
| Q1 25 | $7.6B | $340.0M | ||
| Q4 24 | $7.6B | $406.3M | ||
| Q3 24 | $7.6B | $552.5M | ||
| Q2 24 | $7.6B | $708.1M | ||
| Q1 24 | $6.1B | $877.5M |
股东权益RPRXUI
| Q4 25 | $9.7B | $1.0B | ||
| Q3 25 | $9.6B | $828.4M | ||
| Q2 25 | $9.5B | $668.3M | ||
| Q1 25 | $9.8B | $436.1M | ||
| Q4 24 | $10.3B | $290.4M | ||
| Q3 24 | $10.3B | $188.1M | ||
| Q2 24 | $9.8B | $95.1M | ||
| Q1 24 | $9.9B | $25.9M |
总资产RPRXUI
| Q4 25 | $19.6B | $1.6B | ||
| Q3 25 | $19.3B | $1.5B | ||
| Q2 25 | $18.3B | $1.5B | ||
| Q1 25 | $17.6B | $1.3B | ||
| Q4 24 | $18.2B | $1.2B | ||
| Q3 24 | $18.0B | $1.2B | ||
| Q2 24 | $17.7B | $1.2B | ||
| Q1 24 | $16.1B | $1.2B |
负债/权益比RPRXUI
| Q4 25 | 0.92× | 0.05× | ||
| Q3 25 | 0.93× | 0.16× | ||
| Q2 25 | 0.84× | 0.37× | ||
| Q1 25 | 0.78× | 0.78× | ||
| Q4 24 | 0.74× | 1.40× | ||
| Q3 24 | 0.74× | 2.94× | ||
| Q2 24 | 0.78× | 7.45× | ||
| Q1 24 | 0.62× | 33.92× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $827.1M | $263.9M |
| 自由现金流经营现金流 - 资本支出 | — | $260.3M |
| 自由现金流率自由现金流/营收 | — | 31.9% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | 3.86× | 1.13× |
| 过去12个月自由现金流最近4个季度 | — | $699.5M |
8季度趋势，按日历期对齐
经营现金流RPRXUI
| Q4 25 | $827.1M | $263.9M | ||
| Q3 25 | $702.6M | $198.5M | ||
| Q2 25 | $364.0M | $130.4M | ||
| Q1 25 | $596.1M | $123.6M | ||
| Q4 24 | $742.5M | $152.4M | ||
| Q3 24 | $703.6M | $233.7M | ||
| Q2 24 | $658.2M | $231.4M | ||
| Q1 24 | $664.6M | $163.9M |
自由现金流RPRXUI
| Q4 25 | — | $260.3M | ||
| Q3 25 | — | $193.3M | ||
| Q2 25 | — | $125.2M | ||
| Q1 25 | — | $120.7M | ||
| Q4 24 | — | $150.4M | ||
| Q3 24 | — | $231.1M | ||
| Q2 24 | — | $229.5M | ||
| Q1 24 | — | $160.6M |
自由现金流率RPRXUI
| Q4 25 | — | 31.9% | ||
| Q3 25 | — | 26.3% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 18.2% | ||
| Q4 24 | — | 25.1% | ||
| Q3 24 | — | 42.0% | ||
| Q2 24 | — | 45.2% | ||
| Q1 24 | — | 32.6% |
资本支出强度RPRXUI
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.7% |
现金转化率RPRXUI
| Q4 25 | 3.86× | 1.13× | ||
| Q3 25 | 2.44× | 0.95× | ||
| Q2 25 | 12.06× | 0.49× | ||
| Q1 25 | 2.50× | 0.68× | ||
| Q4 24 | 3.57× | 1.11× | ||
| Q3 24 | 1.29× | 1.83× | ||
| Q2 24 | 6.45× | 2.23× | ||
| Q1 24 | 139.10× | 2.15× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
UI
| Enterprise Technology | $729.0M | 89% |
| Service Provider Technology | $85.9M | 11% |
